Cargando…
Clinical differences between small and large pheochromocytomas and paragangliomas
BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors, most of which are characterized by the release of catecholamine, and range in diameters from less than 1 cm to 10 cm or more. However, knowledge of the differences in clinical features between small and large PPGLs i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034061/ https://www.ncbi.nlm.nih.gov/pubmed/36967797 http://dx.doi.org/10.3389/fendo.2023.1087506 |
_version_ | 1784911126926983168 |
---|---|
author | Zhao, Lin Li, ZhiMao Meng, Xu Fan, Hua Zhang, ZengLei Zhang, ZhaoCai Liu, YeCheng Zhou, XianLiang Zhu, HuaDong |
author_facet | Zhao, Lin Li, ZhiMao Meng, Xu Fan, Hua Zhang, ZengLei Zhang, ZhaoCai Liu, YeCheng Zhou, XianLiang Zhu, HuaDong |
author_sort | Zhao, Lin |
collection | PubMed |
description | BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors, most of which are characterized by the release of catecholamine, and range in diameters from less than 1 cm to 10 cm or more. However, knowledge of the differences in clinical features between small and large PPGLs is insufficient. METHODS: A retrospective analysis of patients with PPGLs treated at our institution between January 2018 and June 2020 was performed. The clinical characteristics of patients were investigated, and comparisons were made between patients with large and small PPGLs. The logistic regression analysis was used to confirm the risk factors, and the receiver operating characteristic curve was used to evaluate the diagnostic performance of the variables. RESULTS: Totally 263 patients were included, including 110 patients in small tumor group and 153 patients in large tumor group. There were more male patients in the large tumor group (p=0.009). More patients had hypertension (p<0.001) and diabetes (p=0.002) in the large tumor group. The 24-h urinary epinephrine (24hU-E) (p < 0.001) and 24-h urinary norepinephrine (24hU-NE) (p=0.002) concentrations were higher in the large tumor group. In terms of tumor location, adrenal-PPGLs were more frequent in the large tumor group (p<0.001). Multivariate logistic regression analysis showed that male sex [odds ratio (OR): 2.871, 95% confidence interval (CI): 1.444–5.711, p=0.003], 24hU-E concentrations (OR: 1.025, 95% CI:1.004–1.047, p=0.020), 24hU-NE concentrations (OR: 1.002, 95%CI: 1.001–1.004, p=0.045), and adrenal-PPGLs (OR: 2.510, 95% CI:1.256–5.018, p=0.009) were positive risk factors for large tumors. Taking above variables into the same model, the area under the receiver operating characteristic curve of the model for predicting the large tumor was 0.772 (95% CI: 0.706–0.834). After the short-term follow-up, there was no significant difference in tumor recurrence between the two groups (p=0.681). CONCLUSIONS: Significant differences in numerous clinical characteristics exist between large and small PPGLs. The male patients were more likely to be with large tumors, and such tumors were more likely to reside on the adrenal glands. Catecholamine measurements also help predict tumor size of PPGLs. Clinical decision-making will benefit from this information. |
format | Online Article Text |
id | pubmed-10034061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100340612023-03-24 Clinical differences between small and large pheochromocytomas and paragangliomas Zhao, Lin Li, ZhiMao Meng, Xu Fan, Hua Zhang, ZengLei Zhang, ZhaoCai Liu, YeCheng Zhou, XianLiang Zhu, HuaDong Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors, most of which are characterized by the release of catecholamine, and range in diameters from less than 1 cm to 10 cm or more. However, knowledge of the differences in clinical features between small and large PPGLs is insufficient. METHODS: A retrospective analysis of patients with PPGLs treated at our institution between January 2018 and June 2020 was performed. The clinical characteristics of patients were investigated, and comparisons were made between patients with large and small PPGLs. The logistic regression analysis was used to confirm the risk factors, and the receiver operating characteristic curve was used to evaluate the diagnostic performance of the variables. RESULTS: Totally 263 patients were included, including 110 patients in small tumor group and 153 patients in large tumor group. There were more male patients in the large tumor group (p=0.009). More patients had hypertension (p<0.001) and diabetes (p=0.002) in the large tumor group. The 24-h urinary epinephrine (24hU-E) (p < 0.001) and 24-h urinary norepinephrine (24hU-NE) (p=0.002) concentrations were higher in the large tumor group. In terms of tumor location, adrenal-PPGLs were more frequent in the large tumor group (p<0.001). Multivariate logistic regression analysis showed that male sex [odds ratio (OR): 2.871, 95% confidence interval (CI): 1.444–5.711, p=0.003], 24hU-E concentrations (OR: 1.025, 95% CI:1.004–1.047, p=0.020), 24hU-NE concentrations (OR: 1.002, 95%CI: 1.001–1.004, p=0.045), and adrenal-PPGLs (OR: 2.510, 95% CI:1.256–5.018, p=0.009) were positive risk factors for large tumors. Taking above variables into the same model, the area under the receiver operating characteristic curve of the model for predicting the large tumor was 0.772 (95% CI: 0.706–0.834). After the short-term follow-up, there was no significant difference in tumor recurrence between the two groups (p=0.681). CONCLUSIONS: Significant differences in numerous clinical characteristics exist between large and small PPGLs. The male patients were more likely to be with large tumors, and such tumors were more likely to reside on the adrenal glands. Catecholamine measurements also help predict tumor size of PPGLs. Clinical decision-making will benefit from this information. Frontiers Media S.A. 2023-03-09 /pmc/articles/PMC10034061/ /pubmed/36967797 http://dx.doi.org/10.3389/fendo.2023.1087506 Text en Copyright © 2023 Zhao, Li, Meng, Fan, Zhang, Zhang, Liu, Zhou and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Zhao, Lin Li, ZhiMao Meng, Xu Fan, Hua Zhang, ZengLei Zhang, ZhaoCai Liu, YeCheng Zhou, XianLiang Zhu, HuaDong Clinical differences between small and large pheochromocytomas and paragangliomas |
title | Clinical differences between small and large pheochromocytomas and paragangliomas |
title_full | Clinical differences between small and large pheochromocytomas and paragangliomas |
title_fullStr | Clinical differences between small and large pheochromocytomas and paragangliomas |
title_full_unstemmed | Clinical differences between small and large pheochromocytomas and paragangliomas |
title_short | Clinical differences between small and large pheochromocytomas and paragangliomas |
title_sort | clinical differences between small and large pheochromocytomas and paragangliomas |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034061/ https://www.ncbi.nlm.nih.gov/pubmed/36967797 http://dx.doi.org/10.3389/fendo.2023.1087506 |
work_keys_str_mv | AT zhaolin clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT lizhimao clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT mengxu clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT fanhua clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT zhangzenglei clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT zhangzhaocai clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT liuyecheng clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT zhouxianliang clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas AT zhuhuadong clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas |